Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMS Group, also known as the Itabashi Medical System Group, is one of Japan's largest comprehensive healthcare provider networks. Founded in 1956, the group operates an extensive infrastructure of over 140 facilities, including general hospitals, specialized clinics, rehabilitation centers, and nursing care facilities across the Kanto and Tohoku regions. The organization provides a full spectrum of medical services ranging from acute emergency care and advanced surgical interventions to preventive medicine and long-term elderly care. While primarily a service provider rather than a drug developer, IMS Group plays a critical role in the Japanese healthcare ecosystem through its large-scale clinical operations and medical education initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMS Group.